Cognitive and functional dementia assessment tools: review of Brazilian literature
Instrumentos de avaliação cognitiva e funcional em demência
Global aging trends
The aging of the world's population is the result of two factors: declines in fertility and increases in life expectancy. Fertility rates have declined in developing countries over the past 30 years. In addition, in developed countries, the largest gain ever in life expectancy at birth occurred during the 20th century, averaging 71% for females and 66% for males. Life expectancy at birth in developed countries now ranges from 76 to 80 years.
In 2000, the worldwide population of persons aged >
65 years was an estimated 420 million. During 2000-2030, the worldwide population aged =65 years is projected to increase by approximately 550 million to 973 million, increasing from 6.9% to 12.0% worldwide, from 15.5% to 24.3% in Europe, from 12.6% to 20.3% in North America, from 6.0% to 12.0% in Asia, and from 5.5% to 11.6% in Latin America and the Caribbean. Between 2000-2030, the number of persons in developing countries aged >
65 years is projected to almost triple, from approximately 249 million in 2000 to an estimated 690 million in 2030, and the developing countries' share of the world's population aged =65 years is projected to increase from 59% to 71%1.
Brazilian aging trends
The Brazilian elderly population (>
60 years) increased from 3 million in 1960 to 14 million by 2002. It is projected to reach 32 million by 20202.
Compared with developed countries, the Brazilian aging process has been faster, had deeper structural changes and has also taken place in a younger population3.
Dementia and aging
Several authors have highlighted that dementia is one of the chronic conditions that will affect a considerably increased number of elderly both in developed and developing countries.
A large number of epidemiological surveys show very similar results such as increasing rates with rising age4.
As adults live longer, the prevalence of Alzheimer's disease, which doubles every 5 years after age 65, is also expected to increase. Approximately 10% of adults aged >
65 years and 47% of adults aged >
85 years suffer from this degenerative and debilitating disease5.
Dementia around the world
The worldwide number of persons with dementia in 2000 was estimated at about 25 million persons. Almost half of the demented persons (46%) lived in Asia, 30% in Europe, and 12% in North America. Fifty-two percent lived in less developed regions. About 6.1% of the population 65 years of age and older suffered from dementia (about 0.5% of the worldwide population) and 59% were female. The number of new cases of dementia in 2000 was estimated to be 4.6 million (one new case every 7 seconds). The forecast indicated a considerable increase in the number of demented elderly from 25 million in the year 2000 to 63 million in 2030 (41 million in less developed regions) and to 114 million in 2050 (84 million in less developed regions)6,7.
Dementia has already been established as one of the major health challenges of this century due to the enormous burden these pathologies impose on health care systems. Dementia is a significant public health problem as it is one of the most common diseases in the elderly and a major cause of disability and mortality (Ritchie and Lovestone, 2002)8. Brazilian dementia prevalence has been estimated at 7.1% (54.1% Alzheimer Disease)9.
Dementia assessment tools
The dementia diagnosis is based on cognitive and functional evaluation. Some diagnostics criteria (DSMIII, DSM-IV) highlight instrumental cognitive domain evaluations.
Use of validated assessment tools provides structure for the assessment process, helps assure consistency, and provides a mechanism for periodic re-evaluation. The assessment approaches also foster a common language for the health care team and consist of measurable parameters that can be used to monitor outcomes10.
Physicians often underestimate the extent of disability that a patient has in basic ADLs. Further, physicians' recording of the level of function in medical notes is poor. By using standardized assessment tools, the evaluation can objectively document physical, cognitive, emotional, and functional conditions. Based on the evidence, assessment tools should be chosen to aid in diagnosis and to measure outcome treatment of dementia. Older patients should be screened by standardized assessment tools in order to improve diagnosis, assessment, and outcome measurement. There are many commonly used tools in dementia assessment11.
Cross-cultural adaptation, validation and reliability
One of the difficulties in ascertaining the number of people with dementia in developing countries is that many older people in these regions have little if any formal education, and often cannot read or write12.
Independent effects of age, sex, education and occupation were identified on scores for most but not all cognitive tests13. Considering that Brazil has a high number of illiterates and low educational subjects, such instruments should be adapted14.
a. To identify the most-used cognitive and functional assessment tools in Brazil, related to dementia diagnosis and treatment outcome;
b. To identify adaptations or normative data, when available.
The literature search was performed up until September 2006. Data were generated from PubMed, LILACS and Portal Periodicos CAPES / Brazilian thesis and dissertations database (PPC) databases using the search terms 'dementia' and 'alzheimer'. For the PubMed search the term "brazil" was also included. The LILACS search only considered abstracts in English or Portuguese.
Data collection criteria: a. Articles with abstract; b. Brazilian abstracts, related to adult Brazilian population; c. Clear mention of assessment tool in the abstract text.
The search result of three databases (Table 1) was submitted to criteria above and the repeated abstracts were excluded. 108 abstracts were selected for the following analysis: a. to identify the instruments used; b. to determine how many of the selected abstracts cited each tool; and c. to search in the mentioned databases for respective test adaptations or normative data.
A total of 52 different assessment tools were identified: 41 cognitive instruments and 11 functional instruments.
The most mentioned assessment tests were the Mini Mental State Examination (64 different abstracts) and the Pfeffer Functional Activities Questionnaire (4 different abstracts). All the mentioned instruments and respective suggestions of adaptations or normative data can be found in Tables 2 and 3.
Many of them only describe the translation process to Portuguese, with some superficial suggestions of validation, replication, normative data or trans-cultural adaptation. Few of them developed the recommended procedures outlined earlier.
Many Brazilian authors have shown the influence of education on test scores: the Mini Mental State Exam-ination15, Verbal Fluency Test16, Boston Naming Test21,22, ADAS-Cog25, CERAD26,Mattis Dementia Rating Scale30,31.
Several dementia assessment tools were identified, where few of these have followed the recommended procedures of validation, replication, normative data or trans-cultural adaptation. In the context of research use this could be acceptable, but these procedures are absolutely necessary for epidemiological surveys.
Psychometric properties of scales and trans-cultural adaptations should be developed to minimize educational influence and decrease false positive diagnosis for cognitive impairment.
Health-care professionals should be trained to recognize and evaluate quality scales and psychometric concepts such as reliability (internal consistency and testretest), validity (construct, content, face and criterion validities), and sensitivity to change (responsiveness).
Methodological problems need to be addressed, particularly development of culture- and education-fair dementia diagnostic procedures.
Consensus on assessment and outcome tools would facilitate multi-center comparative studies. One method of achieving these research goals would be through a consensus conference.
Future research should emphasize functional State, quality of life, and caregiver burden, as well as economic factors and societal perspectives.
1. Public Health and Aging: Trends in Aging - United States and Worldwide. Centers for Disease Control and Prevention, MMWR, 2003;52(06):101-106. Retrieved from the CDC website at: http://www.cdc.gov/MMWR/preview/ mmwrhtml/ mm5206a2.htm.
2. Lima-Costa MF, Veras R. Saúde pública e envelhecimento (Aging and public health). Cad Saúde Pública 2003;19:700- 701.
3. Carvalho JAM, Garcia RA. Enfoque demográfico do envelhecimento da população. Cad Saúde Pública 2003;19:725-733.
4. Wancata J, Musalek M, Alexandrowicz R, Krautgartner M. Number of dementia sufferers in Europe between the years 2000 and 2050. Eur Psychiatry 2003;18:306-313.
5. Lopes MA, Bottino CM. Prevalence of dementia in several regions of the world: analysis of epidemiologic studies from 1994 to 2000. Arq Neuropsiquiatr. 2002;60:61-69.
6. Wimo A,Winblad B, Aguero-Torres H, von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003;17:63-67.
7. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi Consensus Study. Lancet 2005;366 (9503):2112-2117.
8. Berr C,Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacology 2005;15: 463-471.
9. Herrera Jr E, Caramelli P, Nitrini R. Population epidemiologic study of dementia in Catanduva city: state of Sao Paulo, Brazil Rev Psiquiatr Clin 1998;25:70-3.
10. Ensberg M, Gerstenlauer C. Incremental geriatric assessment. Prim Care 2005;32:619-643.
11. Wells JL, Seabrook JA, Stolee P, Borrie MJ, Knoefel F. State of the art in geriatric rehabilitation part II: Clinical challenges. Arch Phys Med Rehabil 2003;84:890-897.
12. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003;361(9361):909-917.
13. Stewart R, Richards M, Brayne C,Mann A. Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery. Int J Geriatr Psychiatry 2001;16:518-527.
14. Jorge MR. Adaptação transcultural de instrumentos de pesquisa em saúde mental. Rev Psiquiatr Clin 1988;25:233- 239.
15. Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr 2003;61: 777-781.
16. Brucki SMD,Malheiros SMF, Okamoto IH, Bertolucci PHF. Normative data for the animals category verbal fluency test in our environment. Arq. Neuropsiquiatr 1997;55:56-61.
17. Nitrini R, Lefèvre BH, Mathias SC, et al. Testes neuropsicológicos de aplicação simples para o diagnóstico das demências. Arq Neuropsiquiatr 1994;52:457-465.
18. Charchat-Fichman H. Heterogeneidade neuropsicológica no processo de envelhecimento: transição do normal aos estágios iniciais da doença de Alzheimer. Tese, Instituto de Psicologia da Universidade de São Paulo, São Paulo; 2003.
19. Bottino CMC, Stoppe A Jr, Scalco AZ, Ferreira RCR, Hototian SR, Scalco MZ. Validade e confiabilidade da versão brasileira do CAMDEX (Abstr). Arq Neuropsiquiatr 2001; 59(Suppl.3): S20.
20. Nascimento E. Adaptation and validation of test WAIS-III for a brazilian context. Tese não-publicada, Curso de Pósgraduação em Psicologia, Universidade de Brasília.Brasília, DF; 2000.
21. Radanovic M,Mansur LL, Scaff M. Normative data for the Brazilian population in the Boston diagnostic aphasia examination: influence of schooling. Braz J Med Biol Res 2004;37:1731-1738.
22. Mansur LL, Radanovic M, Araujo Gde C, Taquemori LY, Greco LL. Boston Naming Test: performance of Brazilian population from Sao Paulo. Pro Fono 2006;18:13-20.
23. Abrisqueta-Gomes J. Avaliação neuropsicológica nas fases inicial e moderada da demência do tipo Alzheimer. Tese, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo; 1999.
24. Okamoto, IH. Cognitive aspects of Alzheimer's disease in clock test: assessment in a Brazilian sample. Tese, Escola Paulista de Medicina da Universidade Federal de São Paulo; 2001.
25. Schultz RR. Desempenho de uma população brasileira na subescala cognitiva da Escala de avaliação da doença de Alzheimer (ADAS-Cog). Braz J Med Biol Res 2001;34:1295-1302.
26. Plass AM. Adaptação para o português da escala de memória de Wechsler-revisada: fidedignidade e validade. Dissertação, Universidade Federal do Rio Grande do Sul; 1991.
27. Bertolucci PHF, Okamoto IH, Toniolo J Neto, Ramos LR, Brucki S MD. Performance of Brazilian population in neuropsychological battery of Consortium to Establish a Registry for Alzheimer's disease (CERAD). Rev Psiquiatr Clin 1998;25:80-83.
28. Mari JJ, Blay SL, Iacoponi E. Reliability of the Brazilian version of the interview for communitary studies. Bol Oficina Sanit Panam 1986;100:77-83.
29. Souza RO, Ignácio FA, Cunha FCR, Oliveira DLG, Moll J. Contributions to the neuropsychology of executive behavior: performance of normal individuals on the Tower of London and Wisconsin tests. Arq Neuropsiquiatr 2001;59: 526-531.
30. Degenszajn J. Avaliacao da memoria de longa duração, recente e tardia, na doença de Alzheimer. Dissertação, Faculdade de Medicina da Universidade de São Paulo, 1998.
31. Porto CS, Fichman HC, Caramelli P, Bahia VS, Nitrini R. Brazilian version of the Mattis dementia rating scale: diagnosis of mild dementia in Alzheimer's disease. Arq. Neuropsiquiatr 2003;61: 339-345.
32. Foss MP, Valle F de AC, Speciali JG. Influência da escolaridade na avaliação neuropsicológica de idosos: aplicação e análise dos resultados da Escala de Mattis para Avaliação de Demência (Mattis Dementia Rating Scale-MDRS). Arq Neuropsiquiatr 2005;63:119-26.
33. Charchat H, Nitrini R, Caramelli P, Sameshima K. Investigação de marcadores clínicos dos estágios iniciais da doença de Alzheimer com testes neuropsicológicos computadorizados. Psicol Reflex Crit 2001;14:305-316.
34. Silva RV. O padrão de desempenho de uma amostra da população geriátrica Brasileira em testes neuropsicológicos.
Dissertação, Escola Paulista de Medicina da Universidade Federal de São Paulo, 2001.
35. Damasceno A, Delicio AM, Mazo DFC, et al. Validation of the Brazilian version of mini-test CASI-S. Arq Neuropsiquiatr 2005; 63:416-421.
36. Marques PRB, Joanette Y, Poissant A, Ska, B. Adequate neuropsychological evaluation to dementias. Arq Neuropsiquiatr 1995;53:147-152.
37. Senhorini MC, Amaro Junior E, de Mello Ayres A, de Simone A, Busatto GF. Phonemic fluency in Portuguesespeaking subjects in Brazil: ranking of letters. J Clin Exp Neuropsychol 2006;28:1191-1200.
38. Chaves ML, Ilha D, Maia AL, Motta E, Lehmen R, Oliveira LM. Diagnosing dementia and normal aging: clinical relevance of brain ratios and cognitive performance in a Brazilian sample. Braz J Med Biol Res 1999;32:1133-1143.
39. Diniz LFM, Cruz MF, Torres VM, Cosenza RM. The Rey auditory-verbal learning test: norms for a brazilian sample.
Rev Bras Neurol 2000;36:79-83.
40. Takada LT, Caramelli P, Charchat-Fichman H, et al.Comparison between two tests of delayed recall for the diagnosis of dementia. Arq Neuropsiquiatr 2006;64:35-40.
41. Ventura MM, Bottino CM. Reliability study of the brazilian version of a structured interview for the diagnosis of dementia. Rev Assoc Med Bras 2001;47:110-116.
42. Blay SL. Diagnostic tests for demencial syndromes. In: Fortes JRA Miguel Filho EC, Ramadam ZBA, Arruda PV. Psiquiatria e medicina interna: Anais do 1º Congresso Brasileiro de Psiquiatria e Medicina Interna; 1988.
43. Fontanari JL. The "token test": elegance and conciseness in the evaluation of understanding the aphasic patients; validative of the reduced version of De Renzi to the Portuguese. Neurobiologia 1989;52:177-218.
44. Pôrto WG. Normatization of 702 image set from the International Affective Picture System (IAPS) in a brazilian elderly sample for emotion and attention testing. Tese, Escola Paulista de Medicina da Universidade Federal de São Paulo; 2005.
45. Nitrini R, Caramelli P, Herrera Jr E, Charchat-Fichman H, Porto CS. Performance in Luria's fist-edge-palm test according to educational level. Cogn Behav Neurol 2005;18: 211-214.
46. Flaks MK, Yassuda MS, Regina AC, et al. The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil. Int Psychogeriatr 2006;18:121-133.
47. Costa EC, Nakatani AYK. Elder's community capacity to develop daily life activities and daily instrumental life activities.Acta Paul Enferm 2006;19:43-48.
48. Andreotti RA, Okuma SS. Validating a test battery of activities of daily living for physically independent elderly. Rev Paul Educ Fis 1999;13:46-66.
49. Goulart F, Santos CC, Teixeira-Salmela LF, Cardos F. Analysis of functional performance in patients with Parkinson's disease. Acta fisiátrica 2004;11:12-16.
50. Guimarães RB. Brazilian versions of stroke scales and clinical assessment tools: a standardization attempt plus improvement of the quality of life. Rev Bras Neurol 2004; 40: 5-13.
From the Department of Psychobiology, Federal University of São Paulo, São Paulo, Brazil.
1 Post-graduate student;
2 Affiliated researcher;
3 Adjunct Professor and Head of Department.
Dr. Luciano G.Vasconcelos -
R. Embaú, 54 - 04039-060 São Paulo SP - Brazil. E-mail: email@example.com